Align Technology, Inc. $ALGN Position Cut by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP decreased its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 78.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 43,440 shares of the medical equipment provider’s stock after selling 161,627 shares during the quarter. Hudson Bay Capital Management LP owned about 0.06% of Align Technology worth $5,440,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the company. Wealth Enhancement Advisory Services LLC grew its holdings in Align Technology by 38.9% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 15,551 shares of the medical equipment provider’s stock worth $2,029,000 after buying an additional 4,359 shares in the last quarter. AE Wealth Management LLC acquired a new stake in Align Technology in the 3rd quarter valued at approximately $650,000. Dana Investment Advisors Inc. bought a new stake in Align Technology during the 3rd quarter valued at $9,991,000. Hussman Strategic Advisors Inc. bought a new stake in Align Technology during the 3rd quarter valued at $3,156,000. Finally, M&G PLC acquired a new position in Align Technology during the 3rd quarter worth $10,904,000. Institutional investors and hedge funds own 88.43% of the company’s stock.

Align Technology News Roundup

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Elliott Investment Management has built a significant, reportedly “major” stake in Align, signalling potential engagement to push for actions that could boost shareholder value (strategic review, cost moves, buybacks or governance changes). This is the primary catalyst behind recent intraday upside. Elliott builds stake in Invisalign maker Align Technology – Reuters
• Positive Sentiment: Market coverage notes and press reports (Bloomberg/Yahoo) echo the stake build and include an updated company response — the combination of activist pressure plus public attention is often perceived as positive for near-term shareholder returns. Market Chatter: Activist Elliott Investment Builds Stake in Align Technology – Yahoo
• Positive Sentiment: Analyst/market reaction: ALGN saw premarket and intraday spikes on the reports and a recent upgrade to Overweight at Barclays, which may lend support to the stock if analysts follow with higher targets. Align Technology Raised to Overweight at Barclays – American Banking News
• Neutral Sentiment: Short interest posts in the data feed show zero shares (and 0 days to cover), which appears to be a reporting anomaly rather than a market signal — treat short-interest headlines with caution until clean data is published.
• Negative Sentiment: Structural headwinds remain: ALGN is still materially below its 2021 peak as dental/demand trends have normalized after the pandemic-era boom. Activist involvement can be positive but may also lead to strategic changes that create uncertainty or execution risk in the near term. Elliott Builds Major Align Stake as Shares Sit Near $172 – Yahoo

Insider Buying and Selling at Align Technology

In other news, EVP John Morici sold 7,969 shares of Align Technology stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total value of $1,508,611.39. Following the transaction, the executive vice president directly owned 8,237 shares of the company’s stock, valued at $1,559,346.47. This trade represents a 49.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.66% of the stock is currently owned by company insiders.

Align Technology Stock Down 1.7%

Shares of NASDAQ ALGN opened at $173.18 on Friday. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $208.30. The company has a market cap of $12.34 billion, a price-to-earnings ratio of 30.60, a P/E/G ratio of 1.92 and a beta of 1.79. The business has a fifty day simple moving average of $176.55 and a 200-day simple moving average of $154.27.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share for the quarter, topping analysts’ consensus estimates of $2.99 by $0.30. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.The firm had revenue of $1.05 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter last year, the business posted $2.44 EPS. Align Technology’s revenue was up 5.3% on a year-over-year basis. As a group, sell-side analysts expect that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently commented on ALGN. Evercore raised their price target on Align Technology from $180.00 to $200.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. UBS Group increased their target price on shares of Align Technology from $175.00 to $185.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Morgan Stanley raised their target price on shares of Align Technology from $154.00 to $169.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. Weiss Ratings upgraded shares of Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, January 16th. Finally, Jefferies Financial Group upped their price target on shares of Align Technology from $155.00 to $185.00 and gave the stock a “hold” rating in a research note on Thursday, February 5th. Seven research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $198.08.

Align Technology Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.